Proven Returns on Investment will Ignite Transformational Growth
21-May-2021
North America
Market Research
K5C7-01-00-00-00
HC03416-NA-MT_25452
This report from Frost & Sullivan Healthcare and Life Sciences focuses on the potential to cater to healthcare needs based on data-driven social determinants of health (SDOH). Although the traditional practice of healthcare involves the use of medical technology and protocols to maintain and restore health, the SDOH concept adds another dimension. In fact, many nonmedical SODH are important factors in a patient’s healthcare journey.
As the world emerges from the global COVID-19 pandemic, there has been a renewed interest in using SDOH as a component of a patient’s medical history. SDOH can play an important role in improving the health of millions of people. Patients can benefit from the knowledge of how lifestyle factors affect their quality of life over many years.
Despite a long-term awareness of SDOH, the concept is at an early stage of large-scale deployment. Frost & Sullivan estimates that by the end of 2020, 40% of the US health systems and commercial payers will have utilized social determinant data of some type in risk assessments, patient outreach, and business decisions. Among the companies targeting SDOH are start-ups that are seeking to focus squarely on SDOH services and software, and larger, established entities that are excited by the potential benefits of SDOH. The larger companies are either designing new programs or seeking to acquire smaller firms to jump-start their SDOH solutions. Given the similarity to the use of data for population health management (PHM), data analytics and PHM companies also are keenly interested in the SDOH space. The common factor across the market is the need for robust data that can be utilized by developing new analytical models. SDOH are truly data driven and will create a new Big Data opportunity in the healthcare industry.
Many challenges will need to be conquered for SDOH to achieve its enormous potential. For example, some providers are concerned that SDOH will result in new and higher costs of healthcare because of the complexity of adding new data to clinical protocols. Specifically, there are worries that the SDOH implementation model will be complex and difficult to standardize, and that the torrent of data will threaten privacy and security. Also of concern is the fact that the SDOH utilization vision is not consistently defined by regulatory agencies, industry advocates, and companies that offer relevant solutions.
The study includes a glimpse of four notable companies in the SDOH space and reviews the types of products and services that comprise SDOH solutions. A major service that pure play SDOH companies offer is the ability to generate referrals that can lead patients and care providers to a solution capable of transforming an SDOH problem to a healthier and productive life.
Author: Victor Camlek
Why Is It Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top Three Strategic Imperatives on the SDOH Market
Growth Opportunities Fuel the Growth Pipeline Engine™
SDOH Context
SDOH Market Segmentation
Selected SDOH Market Competitors and Enablers
SDOH for Providers—Growth Environment
SDOH for Payers—Growth Environment
SDOH for Technology Enablers—Growth Environment
Pure Play SDOH Suppliers—Review of Offerings
Vendor Strategies
Four Companies to Watch
Four Companies to Watch (continued)
SDOH Implementations
SDOH Implementations (continued)
Growth Drivers
Growth Driver Analysis
Growth Driver Analysis (continued)
Growth Driver Analysis (continued)
Growth Restraints
Growth Restraint Analysis
Growth Restraint Analysis (continued)
Growth Restraint Analysis (continued)
Growth Opportunity 1: Defining the Value and Requirements for the Everyday Use of SDOH
Growth Opportunity 1: Defining the Value and Requirements for the Everyday Use of SDOH (continued)
Growth Opportunity 2: Create a .gov Database Devoted to SDOH
Growth Opportunity 2: Create a .gov Database Devoted to SDOH (continued)
Growth Opportunity 3: Establish Business Models That Address the Needs Identified by SDOH
Growth Opportunity 3: Establish Business Models That Address the Needs Identified by SDOH (continued)
Conclusions
List of Exhibits
Legal Disclaimer
Speak directly with our analytics experts for tailored recommendations.
Recent related Digital Health research
06 Oct 2026 | Global | Technology Research
Trends in Laboratory Automation, Global, 2021–2025
This research study provides a comprehensive assessment of the recent trends, technological advancements, and strategic developments shaping the global laboratory automation industry. The analysis traces the evolution of laboratory automation from task-specific automation systems to integrated, inte...
21 Sep 2026 | Europe | Market Research
HLTH Europe 2026: Five Key Takeaways and Growth Opportunities
HLTH Europe 2026, held in Amsterdam, brought together more than 5,000 stakeholders spanning providers, payers, health systems, technology vendors, start-ups, investors, and policymakers, providing a comprehensive view of the evolving European digital health landscape. Across conference sessions and ...
21 Sep 2026 | Global | Frost Radar
Frost Radar: Smart Nutraceuticals for Brain Health, 2026
This Frost Radar evaluates the evolving smart nutraceuticals landscape as consumer awareness of cognitive health, lifestyle-related stress, and healthy aging creates demand for scientifically validated, natural, and multifunctional brain health solutions. The market remains fragmented, with differen...
18 Sep 2026 | Global | Technology Research
Innovations and Growth Opportunities in AI-Enabled Discovery and Diagnostics, Precision Therapeutics, and Next-Generation Vaccine Platforms
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations transforming AI-enabled discovery, precision diagnostics, cell engineering, targeted therapeutics, vaccines, and skin health across oncology, metaboli...
07 Sep 2026 | Global | Technology Research
Synthetic Antibodies and AI-Optimized Immunotherapies
Artificial intelligence is becoming increasingly relevant to antibody discovery and immunotherapy development, supporting target identification, de novo antibody design, antibody engineering, clinical intelligence, and bioprocessing. Advances in generative AI, protein language models, diffusion mode...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Victor Camlek |
| Industries | Healthcare |
| WIP Number | K5C7-01-00-00-00 |
| Is Prebook | No |
| GPS Codes | 9564-B1,9600-B1,9612-B1 |
Explosion of Data Drives the US Social Determinants of Health Market
$2,450.00
Special Price $1,837.50 save 25 %